The purpose of a few hundred people over a year

Published 24 October 2026 · REVIVE LAB UAE Research Desk · 5 min read
Phase 2 establishes whether a compound has the intended effect in the target population, how the effect varies with dose, and what the common adverse events are. It does not establish long-term safety, rare events, durability, or outcomes such as cardiovascular events. The retatrutide phase 2 trials did the first set well and were never designed for the second.

What phase 2 is for

Dose-response above all: several dose groups against placebo, so that the relationship between exposure and effect can be seen and the doses for phase 3 chosen. Alongside, a first characterisation of common adverse events in the intended population, and confirmation that the mechanism produces the expected result in people.

Both retatrutide trials show clear dose-response on their primary endpoints, which is the finding phase 2 exists to produce.

What it cannot show

Rare adverse events, because a few hundred participants cannot detect something that occurs in one in a thousand. Long-term safety, because a year is not long-term. Durability, because the trials ended while weight was still falling. Hard outcomes, because those need thousands of participants and years. Maintenance after stopping, because that was not studied.

None of these is a criticism of the trials; each is a question for a different design.

How the papers themselves frame it

Both state that the results support progression to phase 3. Neither claims efficacy or safety for use. Secondary summaries that drop the word "phase 2" have removed the sentence that tells a reader what kind of evidence they are looking at.

Retatrutide is supplied by REVIVE LAB UAE as an investigational research material for laboratory use only, with identity by mass spectrometry and purity by HPLC for the batch. It is not approved for any use anywhere, and no dosing, administration or protocol guidance is provided.

What it costs

FormatStrengthPriceAvailability
Retatrutide Pack20 mgAED 1010In stock

Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.

Frequently asked

What phase 2 is for?

Dose-response above all: several dose groups against placebo, so that the relationship between exposure and effect can be seen and the doses for phase 3 chosen. Alongside, a first characterisation of common adverse events in the intended population, and confirmation that the mechanism produces the expected result in people.

Does REVIVE LAB UAE provide dosing guidance?

No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.

How fast is delivery in the UAE?

Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.

Retatrutide Pack — in stock, dispatched from Dubai
HPLC-verified, lot certificate on every carton, 24-hour delivery nationwide. Browse the catalogue → All peptides UAE

Related reading

Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.